abstract SUBMISSION Instructions

helpful resources to guide your abstract submission process

Please use the resources below to guide your abstract submission. Note that each abstract will need to be submitted separately.  Note: Late-Breaking Abstracts are those that are submitted between 28 February and 3 April 2024. They are only considered for posters and are not eligible for Travel or Merit Awards.

Quick Step Guide 

  1. Click the “Submit a Late-Breaking Abstract Here” button to begin the submission process.

  2. Our abstract submission portal will guide you through the submission process. Detailed instructions are listed for each step of the process. 

  3. Add abstracts@isscr.org to your contacts to ensure you receive all communications. 

  4. Please contact us at abstracts@isscr.org if you have questions or concerns.  

Session Tracks & Topics

There are six tracks carried throughout the program. Identify the best track for your abstract review and, if applicable, poster presentation.

  • (CI) Clincial Applications: Highlighting the cellular therapy and tissue engineering research that is moving toward the clinic; examining manufacturing and upscaling and presenting clinical trial updates.

  • (DMDD) Disease Modeling and Drug Discovery: Examining advances using stem cells in vivo and in vitro to model development and disease with applications for drug discovery and therapeutics.

  • (EPS) Ethics, Policy & Standards: The ISSCR standing committees representing these three areas integral to stem cell research and regenerative medicine will each design a session for the annual meeting program to be held during the concurrent track sessions in the program.

  • (NT) New Technologies: Exploring the application of emerging technologies to stem cell research.

  • (PD) Pluripotency and Development: Understanding pluripotency and lineage commitment; exploring embryo and organ development.

  • (SSCCR) Somatic Stem Cells, Cancer and Regeneration: Exploring somatic stem cell homeostasis and ageing, regeneration, stem cell-niche interactions, and stem cells in cancer.

Oral consideration: If the abstract will be considered for a short talk in a track concurrent session, you will be asked to choose two track concurrent sessions where it should be considered. These do not need to be in the same track or in the track chosen for abstract review. Late-Breaking Abstract Submissions are not eligible for oral presentations.

Additional details & Guidance

  • Topics and tissue types will be used for abstract review assignment and, if applicable, poster presentation.

    You will choose between the following topics that best describe your abstract:

    • Tissue Stem Cells, the Niche and Regeneration

    • Pluripotent Stem Cells and Reprogramming

    • Modeling Development and Disease

    • Epigenetics

    • Aging, Cancer and Homeostasis

    • Cell and Gene Therapy including manufacturing and commercialization

    • Genome Editing

    • Tissue Engineering

    • Omics and Computational Biology

    • Microscopy and Imaging

    • Science Communication and Advocacy

    • Regulatory Policy

    • Ethics

    You will also choose between the following tissue types that best fit your abstract:

    • Cardiac

    • Epithelial (includes Skin, Gut, Lung)

    • Germline and Early Embryo

    • Hematopoietic, Immune and Endothelial

    • Kidney

    • Liver

    • Mesenchymal Stromal Cells; Adipose and Connective Tissue

    • Musculoskeletal

    • Neural

    • Pancreas

    • No tissue specificity

  • • Average submission may take up to 20 minutes when materials are pre-formatted.

    • Edits are permitted until the submission deadline of 21 February 2024

    • While abstracts are reviewed for inclusion in the program, they do not undergo a formal peer-review process. Presented abstracts are included in the Program and/or Abstract Books and, are citable.

    • Abstract reviewers agree to protect the confidentiality of the unpublished information described in the abstracts.

    • Only abstracts submitted by 21 February 2024 are evaluated for oral presentations and/or Travel, Merit, and Poster awards. Late-breaking abstracts are evaluated for poster presentations only.

    • Poster and oral presenters must present in-person.

  • • Abstracts are reviewed by a committee whose members agree to protect the confidentiality of the unpublished information described in the abstracts.

    • Abstracts will become available to meeting registrants via the abstract book PDF approximately three weeks before the meeting.

    • Abstracts remain under the embargo policy until the time of presentation.

    • The ISSCR will not make abstracts available to the public until after the meeting when the abstract book PDF will be posted to the website.

  • Resources to increase your chances of presenting at the annual meeting: 

    • “Let me Speak! A Reviewers’ Guide to Writing a successful Meeting Abstract” from Stem Cell Reports

    • Our helpful tips for writing a compelling abstract